The Novavax COVID-19 vaccine, sold under the brand names Nuvaxovid and Covovax, among others, is a subunit COVID-19 vaccine developed by Novavax and the... 65 KB (4,734 words) - 04:34, 31 March 2024 |
authorities have granted full or emergency use authorizations for 40 COVID-19 vaccines. Ten vaccines have been approved for emergency or full use by at least one... 318 KB (19,351 words) - 20:00, 21 April 2024 |
A COVID‑19 vaccine is a vaccine intended to provide acquired immunity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus... 192 KB (21,930 words) - 19:29, 15 April 2024 |
Vaxart COVID-19 vaccine is a COVID-19 vaccine candidate developed by Vaxart. Clinical trial number NCT04563702 for "Safety and Immunogenicity Trial of... 2 KB (98 words) - 04:31, 28 August 2023 |